Researchers infused Wistar rats with RS(±)-bupivacaine and S(−)-bupivacaine and tested cardiac electrical activity, cardiac muscle contraction and Ca2+ regulation. They found that the lethal dose of bupivacaine and strength of muscle twitches were higher in 2-week-old rats compared to 16-week-old rats. In addition, 2-week-old rats had a higher increase in Ca2+ release from the sarcoplasmic reticulum preactivated with caffeine than did their older counterparts.
The authors suggest that different mechanisms for intracellular SR Ca2+ regulation in younger rats may partially account for their decreased susceptibility to cardiodepression from bupivacaine.
Read the Anesthesia & Analgesia abstract on bupivacaine-induced cardiotoxicity at different ages.
Read more coverage on anesthesia:
– Society of Anesthesia and Sleep Medicine Encourages Anesthesiologists to Become ‘Perioperative Sleep Physicians’
– ASA Provides Information on Radiation Exposure, Relief Efforts in Japan
– FDA Grants Official Approval for Appeal of Sedasys System
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
